Photobiomodulation for Neurodegenerative Diseases: A Scoping Review
International Journal of Molecular Sciences · 28.01.2024 · 25 (3) · 1625
DOI: 10.3390/ijms25031625 ↗Kurz gefasst
Scoping Review in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.01.2024. Verfasst von Qi Shen und 2 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Laser Life Science, Institute of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, …. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Low-Level Light Therapy, Alzheimer Disease, Parkinson Disease. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, China, Science and Technology Plan Project of Guangzhou, China.
Abstract (Originalsprache)
Neurodegenerative diseases involve the progressive dysfunction and loss of neurons in the central nervous system and thus present a significant challenge due to the absence of effective therapies for halting or reversing their progression. Based on the characteristics of neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), which have prolonged incubation periods and protracted courses, exploring non-invasive physical therapy methods is essential for alleviating such diseases and ensuring that patients have an improved quality of life. Photobiomodulation (PBM) uses red and infrared light for therapeutic benefits and functions by stimulating, healing, regenerating, and protecting organizations at risk of injury, degradation, or death. Over the last two decades, PBM has gained widespread recognition as a non-invasive physical therapy method, showing efficacy in pain relief, anti-inflammatory responses, and tissue regeneration. Its application has expanded into the fields of neurology and psychiatry, where extensive research has been conducted. This paper presents a review and evaluation of studies investigating PBM in neurodegenerative diseases, with a specific emphasis on recent applications in AD and PD treatment for both animal and human subjects. Molecular mechanisms related to neuron damage and cognitive impairment are scrutinized, offering valuable insights into PBM’s potential as a non-invasive therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MOE Key Laboratory of Laser Life Science, Institute of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, China.
- Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province, China
- Science and Technology Plan Project of Guangzhou, China
- China Postdoctoral Science Foundation
Zitieren
APA
Shen, Q., Guo, H., & Yan, Y. (2024). Photobiomodulation for Neurodegenerative Diseases: A Scoping Review. International Journal of Molecular Sciences, 25(3), 1625. https://doi.org/10.3390/ijms25031625
Vancouver
Shen Q, Guo H, Yan Y. Photobiomodulation for Neurodegenerative Diseases: A Scoping Review. International Journal of Molecular Sciences. 2024;25(3):1625. doi:10.3390/ijms25031625
BibTeX
@article{Shen2024,
author = {Shen, Qi and Guo, Haoyun and Yan, Yihua},
title = {Photobiomodulation for Neurodegenerative Diseases: A Scoping Review},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {3},
pages = {1625},
doi = {10.3390/ijms25031625}
}
EUVIMED